Cable Hill Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-62
| Closed | -$7K | – | 941 |
|
|
2018
Q1 | $7K | Sell |
62
-122
| -66% | -$13.8K | ﹤0.01% | 591 |
|
|
2017
Q4 | $23K | Sell |
184
-276
| -60% | -$34.5K | 0.01% | 363 |
|
|
2017
Q3 | $65K | Buy |
460
+62
| +16% | +$8.76K | 0.03% | 209 |
|
|
2017
Q2 | $48K | Buy |
398
+263
| +195% | +$31.7K | 0.03% | 155 |
|
|
2017
Q1 | $16K | Hold |
135
| – | – | 0.01% | 309 |
|
|
2016
Q4 | $17K | Sell |
135
-5
| -4% | -$630 | 0.01% | 301 |
|
|
2016
Q3 | $17K | Buy |
140
+5
| +4% | +$607 | 0.01% | 318 |
|
|
2016
Q2 | $17K | Hold |
135
| – | – | 0.01% | 281 |
|
|
2016
Q1 | $20K | Hold |
135
| – | – | 0.02% | 241 |
|
|
2015
Q4 | $26K | Hold |
135
| – | – | 0.02% | 205 |
|
|
2015
Q3 | $22K | Hold |
135
| – | – | 0.02% | 238 |
|
|
2015
Q2 | $25K | Hold |
135
| – | – | 0.02% | 251 |
|
|
2015
Q1 | $23K | Hold |
135
| – | – | 0.02% | 259 |
|
|
2014
Q4 | $25K | Buy |
+135
| New | +$25K | 0.02% | 249 |
|